Activity Description:

This presentation will provide healthcare professionals with the latest advancements in the fields of solid organ transplantation, specifically liver and kidney transplants, as well as cutting-edge techniques in hepato-pancreato-biliary (HPB) surgery. The session will cover novel surgical approaches, innovations in immunosuppressive therapy, and advancements in post-operative care that enhance patient outcomes. Additionally, attendees will gain insight into the management of complex transplant patients and the evolving role of minimally invasive surgery in HPB procedures. Through case-based discussions and expert insights, this presentation aims to equip practitioners with the knowledge to improve clinical decision-making in transplantation and HPB surgery. The session will also highlight the multidisciplinary approach to patient management, focusing on collaboration between surgeons, hepatologists, nephrologists, medical oncologists, hospitalists, and allied healthcare providers. 

Target Audience: 

This course is designed for hospitalists, nurse practitioners, physician assistants, advance practice nurses, registered nurses, allied health professionals, physicians and residents.

Learning Objectives:

• Review the latest innovations in liver and kidney transplantation including use of machine perfusion devices.
• Analyze data for use of novel therapies in Hepato-Pancreato-Biliary malignancies including immunotherapy, hepatic artery infusion pumps, liver directed therapies, and transplant oncology.
• Summarize the role of minimally invasive surgery/Robotic surgery and perioperative Enhanced Recovery after Surgery (ERAS) protocols in both Transplant Surgery and Hepato-Pancreato-Biliary Surgery/Complex Surgical Oncology.

02.19.25 PSL Grand Rounds Flyer.pdf

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.